Aarti Pharmalabs Limited

Web: aartipharmalabs.com NSE: AARTIPHARM BSE: 543748 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

863 5(-1%)

Near 52W High of 946

Volume

18L as on 23, Jun

Open

573

High

580

Low

572

868

VWAP

712

52 Week High

946

52 Week Low

585

Viand Research Rating

Quality Score

56/100

Growth Score

15/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

7,823

No. of Shares

9.07

P/E

27.47

P/B

3.32

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

12.08

ROCE

Profit Growth

Listing Date

30-Jan-23

Promoter Holding

42.86%

FII Holding

8.17%

DII Holding

7.22%

Price Chart

Price Performance

1 Week11%

1 Month0%

3 Months15%

6 Months3%

1 Year3%

YTD3%

Moving Average

5 Day SMA677

10 Day SMA655

20 Day SMA647

30 Day SMA668

50 Day SMA690

61 Day SMA681

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	719	685	709	719
Resistance 2	709	683	699	709
Resistance 1	693	680	693	693
Pivot Point	684	678	684	684
Support 1	668	676	674	668
Support 2	658	673	668	658
Support 3	643	671	658	643

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023
Promoters	(-0.21) 42.86%	(0.01) 43.08%	(0.21) 43.10%	(-0.81) 42.88%	(-0.61) 43.72%	(-0.41) 44.29%	(-1.51) 44.65%	(-0.41) 46.10%	(0.01) 46.46%	(0.01) 46.46%	(0.21) 46.46%	(0.31) 46.30%	(0.01) 45.98%	(0.01) 45.98%
FIIs	(-0.21) 8.17%	(0.71) 8.39%	(-0.31) 7.69%	(0.71) 8.02%	(0.01) 7.34%	(-1.31) 7.36%	(1.31) 8.64%	(0.31) 7.38%	(-1.31) 7.07%	(0.21) 8.33%	(-0.31) 8.17%	(1.01) 8.45%	(-0.31) 7.43%	(0.01) 7.69%
DIIs	(-0.21) 7.22%	(-0.31) 7.40%	(0.71) 7.66%	(-0.91) 6.95%	(0.31) 7.80%	(-2.81) 7.53%	(-1.01) 10.36%	(-0.11) 11.35%	(1.51) 11.47%	(0.11) 9.97%	(-0.61) 9.91%	(-0.11) 10.51%	(-3.01) 10.65%	(0.01) 13.68%
Government	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%
Public	41.74%	41.10%	41.54%	42.12%	41.12%	40.81%	36.33%	35.17%	35.00%	35.24%	35.45%	34.73%	35.92%	32.64%
No. of Shareholders	176,506	179,373	184,489	190,655	187,039	196,314	185,111	185,436	189,012	204,122	215,796	226,286	258,239	276,664

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
Sales	536	583	432	418	386	564	538	458	555	506	449	440	458	485	472	531	457	460
Sales Growth % (YoY)	38.7%	3.4%	-19.6%	-8.7%	-30.5%	11.5%	19.9%	4.2%	21.2%	4.3%	-4.9%	-17.2%	0.2%	5.4%	-	-	-	-
Sales Growth % (QoQ)	-8.1%	35%	3.3%	8.3%	-31.6%	4.8%	17.5%	-17.5%	9.7%	12.7%	2%	-3.9%	-5.6%	2.8%	-11.1%	16.2%	-0.7%	-
Expenses	400	470	330	344	293	418	409	364	459	388	353	352	373	405	385	441	371	385
Operating Profit	136	113	102	74	93	146	129	94	96	118	96	88	85	80	86	90	86	76
OPM %	25	19	24	18	24	26	24	20	17	23	21	20	19	16	18	17	19	16
Other Income	8	14	2	0	2	-2	5	4	2	2	1	1	0	1	0	1	0	3
Interest	13	17	13	11	7	7	10	6	5	5	4	4	4	6	5	6	4	5
Depreciation	30	28	29	25	23	23	23	21	20	19	19	18	17	16	16	17	14	14
Profit before tax	101	82	63	39	65	115	101	72	74	96	74	67	64	59	65	69	68	59
Tax %	25	25	24	28	24	23	26	24	25	32	29	23	26	27	27	26	24	18
Net Profit	76	61	48	28	50	88	74	55	55	65	53	52	47	43	48	51	52	49
Net Profit Growth % (QoQ)	24.6%	27.1%	71.4%	-44%	-43.2%	18.9%	34.5%	-	-15.4%	22.6%	1.9%	10.6%	9.3%	-10.4%	-5.9%	-1.9%	6.1%	-
Net Profit Growth % (YoY)	52%	-30.7%	-35.1%	-49.1%	-9.1%	35.4%	39.6%	5.8%	17%	51.2%	10.4%	2%	-9.6%	-12.2%	-	-	-	-
TTM Net Profit	213	187	214	240	267	272	249	228	225	217	195	190	189	194	200	152	101	0
EPS in Rs	8.4	6.74	5.29	3.08	5.46	9.75	8.16	6.03	6.12	7.2	5.82	5.72	5.2	4.73	5.26	0	0	0

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Sales	1819	2115	1853	1945	1200	0
Sales Growth %	-14%	14.2%	-4.8%	62.1%	-	-
Expenses	1450	1651	1467	1603	993	0
Operating Profit	369	464	386	342	207	0
OPM %	20	22	21	18	17	0
Other Income	15	10	5	2	3	0
Interest	47	27	17	21	12	0
Depreciation	104	87	73	63	42	0
Profit before tax	233	361	300	261	155	0
Tax %	25	24	28	26	21	0
Net Profit	175	272	217	193	122	0
Net Profit Growth %	-35.7%	25.3%	12.4%	58.2%	-	-
EPS in Rs	19.27	30.05	23.93	21.35	0	0
Dividend Payout %	18	17	13	9	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Cash from Operating Activity	262	332	216	250	-44
Cash from Investing Activity	-431	-414	-215	-158	-139
Cash from Financing Activity	171	65	10	-163	260
Net Cash Flow	2	-17	12	-71	78

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Equity Capital	45	45	45	45	45	45	0.25	0.25
Reserves	2079	2001	1945	1811	1712	1513	1386	0
Borrowings	754	659	413	386	285	215	338	0
Other Liabilities	603	561	503	533	540	470	315	0
Total Liabilities	3482	3266	2906	2777	2582	2244	2040	0
Fixed Assets	1525	1515	1137	1204	1033	926	782	0
CWIP	305	160	374	116	137	102	187	0
Investments	194	187	77	94	107	87	32	0
Other Assets	1457	1403	1319	1362	1305	1130	1038	0
Total Assets	3482	3266	2906	2777	2582	2244	2040	0

Delivery

Delivery Data: AARTIPHARM

#	Date	651 43% 933	Value (Cr)	Q/T 51	Del 34	Del 66
1	4-Sep	859	40	24	53	21
2	3-Sep	868	33	21	37	12
3	2-Sep	867	30	17	35	10
4	1-Sep	865	44	21	37	16
5	31-Aug	845	44	20	44	19
6	28-Aug	841	23	18	42	10
7	27-Aug	814	33	19	49	16
8	26-Aug	837	37	18	34	13
9	25-Aug	835	33	25	46	15
10	24-Aug	843	63	23	38	24
11	21-Aug	817	42	19	50	21
12	20-Aug	829	19	15	40	7
13	19-Aug	834	32	18	39	12
14	18-Aug	875	28	18	34	10
15	17-Aug	862	45	21	39	17
16	14-Aug	851	34	21	39	13
17	13-Aug	874	53	31	22	12
18	12-Aug	889	322	33	13	41
19	11-Aug	884	1340	42	10	130
20	10-Aug	823	255	95	27	69
21	7-Aug	686	12	13	50	6
22	6-Aug	692	11	12	52	6
23	5-Aug	683	8	10	56	5
24	4-Aug	690	14	8	51	7
25	3-Aug	676	6	11	47	3
26	31-Jul	667	10	11	48	5
27	30-Jul	674	6	11	57	3
28	29-Jul	683	11	13	59	6
29	28-Jul	676	4	7	50	2
30	27-Jul	684	7	9	52	4
31	24-Jul	674	8	9	42	3
32	23-Jul	660	16	13	47	7
33	22-Jul	673	17	15	52	9
34	21-Jul	702	6	10	43	3
35	20-Jul	698	7	9	45	3
36	17-Jul	708	7	8	45	3
37	16-Jul	717	9	10	46	4
38	15-Jul	718	14	10	44	6
39	14-Jul	710	12	12	42	5
40	13-Jul	718	9	14	53	5
41	10-Jul	709	10	11	57	6
42	9-Jul	703	9	11	52	5
43	8-Jul	686	11	14	50	5
44	7-Jul	700	9	10	53	5
45	6-Jul	705	9	14	47	4
46	3-Jul	706	12	14	50	6
47	2-Jul	697	18	21	57	11
48	1-Jul	702	17	16	52	9
49	30-Jun	680	17	20	51	9
50	29-Jun	675	20	18	45	9

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	7,823c	179c	2.24
03-Sep	8,002c	283c	3.67
01-Sep	7,719c	81c	1.04
31-Aug	7,800c	418c	5.66
27-Aug	7,382c	362c	4.67
26-Aug	7,744c	218c	2.89
25-Aug	7,526c	100c	1.31
24-Aug	7,626c	184c	2.47
21-Aug	7,443c	127c	1.68
19-Aug	7,570c	360c	4.54
18-Aug	7,930c	95c	1.22
17-Aug	7,835c	84c	1.09
14-Aug	7,750c	201c	2.53
13-Aug	7,952c	155c	1.91
12-Aug	8,107c	64c	0.78
11-Aug	8,170c	707c	9.48
10-Aug	7,463c	1,259c	20.29
07-Aug	6,204c	60c	0.96
06-Aug	6,265c	64c	1.02
05-Aug	6,201c	116c	1.83
04-Aug	6,317c	242c	3.99
31-Jul	6,075c	94c	1.53
30-Jul	6,169c	7c	0.12
29-Jul	6,176c	45c	0.73
28-Jul	6,131c	63c	1.01
27-Jul	6,194c	73c	1.19
24-Jul	6,121c	0	0

Stock Checklist

Price is above from 52 week high low average: 77%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 28 fund scheme(s) across 11 fund house(s) as of Aug26 · Total value ₹93 Cr · 4 increasing / 10 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
ICICI Prudential Mutual Fund	4	0.37%	-0.06%	21.4
UTI Mutual Fund	2	0.73%	-0.24%	20
Motilal Oswal Mutual Fund	4	0.37%	-0.09%	18.3
WhiteOak Capital Mutual Fund	2	0.90%	+0.12%	12.7
HDFC Mutual Fund	2	0.01%	-0.01%	9
Taurus Mutual Fund	2	0.86%	+0.05%	6
Unifi Mutual Fund	2	1.25%	-0.42%	5.7
Bandhan Mutual Fund	4	0.07%	-0.03%	0.1
Groww Mutual Fund	2	0.02%	-	0.1
Angel One Mutual Fund	2	0.02%	-	0
Mirae Asset Mutual Fund	2	0.02%	-	0

Aarti Pharmalabs Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements